Answer
Safety and efficacy have not been established in people under 18, and the selected products do not recommend paediatric use.
Sources for this answer
- Supralip 160mg — Current selected SmPCemc · Summary of Product Characteristics
- Fenofibrate 200 mg Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.